Post-IPO Equity - Blueprint Medicines - Dec 11, 2017 Funding Round Profile - Cointime

Bitcoin $99,305.34 +0.95%
Ethereum $3,288.89 -2.92%
BNB $621.30 -0.54%
Optimism $2.10 +0.44%
Arbitrum $0.77 -1.50%
Solana $254.13 -1.63%
Polygon $0.47 +5.26%
Cosmos $7.23 +14.13%
Avalanche $39.24 +9.11%

Bitcoin $99,305.34 +0.95%
Ethereum $3,288.89 -2.92%
BNB $621.30 -0.54%
Optimism $2.10 +0.44%
Arbitrum $0.77 -1.50%
Solana $254.13 -1.63%
Polygon $0.47 +5.26%
Cosmos $7.23 +14.13%
Avalanche $39.24 +9.11%

Blueprint Medicines

company

Funding Round

Post-IPO Equity

Money Raised

$ 325.50M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion

Historical Financing

Announced Date	Round	Money Raised	Investors
Nov 12, 2014	Series C	$ 50M	Casdin Capital,Cowen Group,etc.	Detail
Apr 11, 2011	Series A	$ 40M	F-Prime Capital,Third Rock Ventures	Detail
Dec 6, 2016	Post-IPO Equity	$ 134.50M		Detail
Mar 29, 2017	Post-IPO Equity	$ 215.60M		Detail
Jan 7, 2014	Series B	$ 25M	Biotechnology Value Fund,Casdin Capital,etc.	Detail
Jan 1, 2012	Series Unknown	0	Eight Roads Ventures	Detail
Apr 27, 2015	IPO	$ 147M		Detail